GW PHARMACEUTICALS PLC Capital Expenditures
GW PHARMACEUTICALS PLC reported Capital Expenditures of $7.94 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2021-05-03
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for the quarter ending 2021-03-31 was $7.94M, a 24.76% increase year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $4.33M, a 58.69% decline year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for the quarter ending 2020-09-30 was $2.90M, a 60.85% decline year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was $5.00M, a 52.04% decline year-over-year.
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for fiscal 2020 was $18.59M, a 53.98% decline from fiscal 2019.
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for fiscal 2019 was $40.39M.
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for fiscal 2018 was $31.36M, a 62.62% increase from fiscal 2017.
- GW PHARMACEUTICALS PLC payments to acquire property, plant, and equipment for fiscal 2017 was $19.29M, a 58.18% increase from fiscal 2016.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2021-03-31 | $7.94M 10-Q · filed 2021-05-03 | $12.26M derived: sum of 2 quarters · filed 2021-05-03 | $15.16M derived: sum of 3 quarters · filed 2021-05-03 | $20.16M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $7.22M derived: sum of 2 quarters · filed 2021-02-26 | $12.22M derived: sum of 3 quarters · filed 2021-02-26 | $18.59M 10-K · filed 2021-02-26 |
| 2020-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.90M derived: sum of 2 quarters · filed 2020-11-05 | $14.26M 10-Q · filed 2020-11-05 | $24.73M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $11.36M 10-Q · filed 2020-08-07 | $21.83M derived: sum of 3 quarters · filed 2021-05-03 | $29.23M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | $6.36M 10-Q · filed 2021-05-03 | $16.83M derived: sum of 2 quarters · filed 2021-05-03 | $24.23M derived: sum of 3 quarters · filed 2021-05-03 | $34.66M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $10.47M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $17.87M derived: sum of 2 quarters · filed 2021-02-26 | $28.30M derived: sum of 3 quarters · filed 2021-02-26 | $40.39M 10-K · filed 2021-02-26 |
| 2019-09-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $17.83M derived: sum of 2 quarters · filed 2020-11-05 | $29.91M 10-Q · filed 2020-11-05 | $48.60M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $10.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $22.52M 10-Q · filed 2020-08-07 | $41.20M derived: sum of 3 quarters · filed 2021-02-26 | $50.14M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $12.09M 10-Q · filed 2020-05-11 | $30.77M derived: sum of 2 quarters · filed 2021-02-26 | $39.71M derived: sum of 3 quarters · filed 2021-02-26 | $48.33M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $18.69M 10-K · filed 2021-02-26 | $27.63M derived: sum of 2 quarters · filed 2021-02-26 | $36.24M derived: sum of 3 quarters · filed 2021-02-26 | $42.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | $8.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $17.56M derived: sum of 2 quarters · filed 2019-11-06 | $23.61M 10-Q · filed 2019-11-06 | $31.36M 10-K · filed 2021-02-26 |
| 2018-06-30 | $8.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $14.68M 10-Q · filed 2019-08-07 | $22.42M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-03-31 | $6.06M 10-Q · filed 2019-05-08 | $13.80M derived: sum of 2 quarters · filed 2021-02-26 | ||
| 2017-12-31 | $7.75M 10-K · filed 2021-02-26 | |||
| 2017-09-30 | $19.29M 10-K · filed 2020-02-27 | |||
| 2016-09-30 | $12.19M 10-KT · filed 2019-02-28 |